Bayer Corp. is a global life sciences company founded in 1863 and headquartered in Leverkusen, Germany, focusing on pharmaceuticals, consumer health, crop science, and animal health. The company is renowned for its innovative products such as aspirin, healthcare solutions, and agricultural seeds and chemicals.
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| BAYNGR 6.65% 2028-02-15 USDBayer Corp. | United States | 2028-02-15 | 6.650 | 4.36 |
| BAYNGR 6.65% 2028-02-15 USDBayer Corp. | United States | 2028-02-15 | 6.650 | 4.36 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Bayer Corp. began issuing bonds in the 1990s as a means to finance its expansion and strategic acquisitions. Notable among these was a €5 billion bond issuance in 2016, utilized for financing the acquisition of Monsanto. Current yields on Bayer’s bonds are competitive within the industry, and the company has a robust credit rating, reflecting strong financial health. Additionally, Bayer’s bonds often feature callable options, providing flexibility and strategic advantage in managing debt obligations. Recent reports indicate a continued focus on sustainability and innovation, enhancing investor interest in their debt offerings.